Cross-border medical devices in Japan must comply with PMDA regulatory requirements and NHI reimbursement policies. Local agents often facilitate the process, ensuring alignment with Japanese standards. Reimbursement decisions by MHLW and Chuikyo consider clinical data, cost-effectiveness, and market relevance. Foreign pricing may influence negotiations, but devices must fit Japan’s healthcare system needs.
